Pfizer Inc. has recalled 62,088 bags of Heparin Sodium (heparin sodium) injection because the bags have the potential to leak. This defect causes a lack of assurance of sterility for the medication, which is intended for intravenous administration. The recall includes 1,000 mL bags distributed nationwide by Hospira, Inc. with lot number 5935283.
Leaking bags can compromise the sterility of the injectable medication, allowing microorganisms to enter the solution. Using a contaminated product poses a serious risk of infection or systemic illness to patients.
Distributed by Hospira, Inc. Case and Single Unit NDC codes both affected.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.